Cytochrome P450 2C11: Escherichia coli Expression, Purification, Functional Characterization, and Mechanism-Based Inactivation of the Enzyme

By Licad-Coles E.   He K.   Yin H.   Correia M.A.  

Archives of Biochemistry and Biophysics, Vol. 338, Iss. 1, 1997-02 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

Mechanism-based inhibition of human cytochrome P4503A4 by domperidone

By Chang S.-Y.   Fancher R.M.   Zhang H.   Gan J.  

Xenobiotica, Vol. 40, Iss. 2, 2010-02 ,pp. : 138-145

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

By Melet A.   Assrir N.   Jean P.   Pilar Lopez-Garcia M.   Marques-Soares C.   Jaouen M.   Dansette P.M.   Sari M-A.   Mansuy D.  

Archives of Biochemistry and Biophysics, Vol. 409, Iss. 1, 2003-01 ,pp. : 80-91

Elsevier

Access to resources Recommend Favorite

Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment

By Venkatakrishnan K.   Obach R. S.   Rostami-Hodjegan A.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1225-1256

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel

By Jin Bo   Ni Huan-Chun   Shen Wei   Li Jian   Shi Hai-Ming   Li Yong  

Molecular Biology Reports, Vol. 38, Iss. 3, 2011-03 ,pp. : 1697-1702

Springer Publishing Company

Access to resources Recommend Favorite